Skip to main content

Table 3 Body weight gain and T3 levels after 16 weeks of iodine treatment.

From: Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)

Treatment

Body weight gain (g)

T3 (ng/dl)

Control

154 ± 15

63.7 ± 10

MNU

157 ± 12

67.9 ± 3

Control + I2

152 ± 9

63.2 ± 11

MNU + I2

150 ± 16

60.2 ± 5.6